Dr. Agarwal's Health Care Allots 1,50,282 Equity Shares Under Employee Stock Option Scheme

1 min read     Updated on 09 Apr 2026, 02:06 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dr. Agarwal's Health Care Limited allotted 1,50,282 equity shares under its ESOP 2022 scheme, approved by the Nomination and Remuneration Committee on April 08, 2026. The allotment increased paid-up capital from ₹31,68,07,506 to ₹31,69,57,788. Shares were issued across three tranches at exercise prices of ₹84.93, ₹129.88, and ₹135.00 respectively. The newly issued shares rank pari passu with existing equity shares.

powered bylight_fuzz_icon
37226208

*this image is generated using AI for illustrative purposes only.

Dr. Agarwal's Health Care Limited has completed the allotment of 1,50,282 equity shares to eligible employees under its Employee Stock Option Scheme 2022. The Nomination and Remuneration Committee of the Board of Directors approved this allotment through a circular resolution dated April 08, 2026.

Share Capital Enhancement

The allotment has resulted in an increase in the company's paid-up equity share capital. The capital structure change is detailed below:

Parameter: Details
Previous Paid-up Capital: ₹31,68,07,506
New Paid-up Capital: ₹31,69,57,788
Previous Share Count: 31,68,07,506 equity shares
New Share Count: 31,69,57,788 equity shares
Face Value per Share: ₹1 each

ESOP Exercise Details

The shares were allotted under the Dr. Agarwal's Health Care Limited – Employees Stock Option Scheme 2022 to employees of the company and its subsidiaries. The exercise was completed across multiple tranches with different pricing structures:

Tranche Details: Shares Exercise Price
Tranche 1: 5,571 shares ₹84.93 each
Tranche 2: 1,01,730 shares ₹129.88 each
Tranche 3: 42,981 shares ₹135.00 each
Total Shares: 1,50,282 shares -

Premium Structure

The premium component for each tranche reflects the difference between exercise price and face value:

  • Tranche 1: Premium of ₹83.93 per share
  • Tranche 2: Premium of ₹128.88 per share
  • Tranche 3: Premium of ₹134.00 per share

Regulatory Compliance

The allotment was conducted in compliance with Regulation 10(c) of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has informed both BSE Limited and National Stock Exchange of India Limited about this development.

Share Characteristics

The newly allotted equity shares carry the same rights and privileges as existing shares, being ranked pari passu with the company's current equity shares. The shares have been assigned distinctive numbers from 31,68,07,507 to 31,69,57,788 and carry the ISIN INE943P01029 for demat purposes.

Historical Stock Returns for Dr. Agarwal's Health Care

1 Day5 Days1 Month6 Months1 Year5 Years
+0.18%+4.52%-2.99%-13.46%+3.11%+8.51%

How will the significant variation in exercise prices across tranches (₹84.93 to ₹135.00) impact employee retention and future ESOP participation rates?

What percentage of the total ESOP pool has been utilized with this allotment, and when might the next major exercise window occur?

Could this ESOP exercise signal management's confidence in the stock's future performance given the premium pricing structure?

Dr. Agarwal's Health Care
View Company Insights
View All News
like16
dislike

Dr. Agarwal's Health Care Limited Submits Quarterly Compliance Certificate for Q4 FY26

1 min read     Updated on 07 Apr 2026, 02:03 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dr. Agarwal's Health Care Limited filed its quarterly compliance certificate under SEBI Regulation 74(5) for Q4 FY26 on April 06, 2026. The certificate, confirmed by registrar KFin Technologies Limited, certifies that securities dematerialization/rematerialization details for the quarter ended March 31, 2026 were furnished to BSE and NSE. Company Secretary Thanikainathan Arumugam signed the submission, ensuring regulatory compliance with SEBI depositories regulations.

powered bylight_fuzz_icon
37053219

*this image is generated using AI for illustrative purposes only.

Dr. Agarwal's Health Care Limited has submitted its mandatory quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The filing confirms the company's adherence to regulatory requirements regarding securities dematerialization and rematerialization activities during the period.

Regulatory Compliance Filing

The certificate was submitted to both BSE Limited and National Stock Exchange of India Limited on April 06, 2026. The document was signed by Thanikainathan Arumugam, Company Secretary and Compliance Officer of Dr. Agarwal's Health Care Limited.

Parameter: Details
Filing Date: April 06, 2026
Quarter Ended: March 31, 2026
Regulation: SEBI Regulation 74(5)
Signatory: Thanikainathan Arumugam
Designation: Company Secretary and Compliance Officer

Registrar Confirmation

KFin Technologies Limited, serving as the Registrar and Share Transfer Agent for Dr. Agarwal's Health Care Limited, issued the confirmation certificate dated April 01, 2026. The certificate was signed by Ganesh Chandra Patro, Deputy Vice President at KFin Technologies Limited.

The registrar certified that details of securities dematerialized and rematerialized during the quarter ended March 31, 2026 have been furnished to all stock exchanges where the company's shares are listed, as required under SEBI (Depositories and Participants) Regulations 2018.

Stock Exchange Details

The compliance certificate was submitted to both major Indian stock exchanges where the company's shares are traded:

Exchange: Symbol/Code
BSE Limited: 544350
National Stock Exchange: AGARWALEYE

Company Information

Dr. Agarwal's Health Care Limited operates from its registered office located at 6th Floor, Menon Eternity, 1st Main Road, Austin Nagar, Alwarpet, Chennai - 600 018. The company maintains its regulatory compliance through systematic filing of mandatory certificates and disclosures as required by SEBI regulations.

The quarterly certificate under Regulation 74(5) is a mandatory compliance requirement that ensures transparency in the dematerialization and rematerialization process of securities, providing stakeholders with regular updates on share transfer activities.

Historical Stock Returns for Dr. Agarwal's Health Care

1 Day5 Days1 Month6 Months1 Year5 Years
+0.18%+4.52%-2.99%-13.46%+3.11%+8.51%

Will Dr. Agarwal's Health Care Limited announce any expansion plans or new healthcare facility openings in the upcoming quarters?

How might the company's dematerialization activities reflect on potential institutional investor interest or retail participation changes?

What impact could regulatory changes in the healthcare sector have on Dr. Agarwal's operational compliance requirements beyond securities regulations?

Dr. Agarwal's Health Care
View Company Insights
View All News
like19
dislike

More News on Dr. Agarwal's Health Care

1 Year Returns:+3.11%